4.7 Review

Recent progress in tumor photodynamic immunotherapy

Journal

CHINESE CHEMICAL LETTERS
Volume 31, Issue 7, Pages 1709-1716

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.cclet.2020.02.007

Keywords

Cancer therapy; Photodynamic therapy; Immunotherapy; Reactive oxygen species; Singlet oxygen

Funding

  1. National Natural Science Foundation of China (NSFC) [81773667]
  2. NSFC Projects of International Cooperation and Exchanges [81811540416]
  3. China Pharmaceutical University [2242019K3DNZ2]
  4. Southeast University [2242019K3DNZ2]
  5. Nanjing Medical University [2242019K3DNZ2]

Ask authors/readers for more resources

Photodynamic therapy (PDT) is a promising alternative approach for effective cancer treatment, which can directly destroy local tumor cells due to the generation of cytotoxic singlet oxygen and reactive oxygen species (ROS) in the tumor cells. Intriguingly, PDT-mediated cell death is also associated with anti-tumor immune response. However, immunosuppression of tumor microenvironment is able to limit the immune response induced by PDT, it is therefore necessary to combine with immunocheckpoint inhibitor and immunoadjuvant for synergistic treatment of tumors. Herein, the recent advances of PDT, immunotherapy, and photodynamic immunotherapy are reviewed (C) 2020 Chinese Chemical Society and Institute of Materia Medica, Chinese Academy of Medical Sciences. Published by Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available